NEUROCRINE BIOSCIENCES INC (NBIX) Stock buybacks 2022–2025
NEUROCRINE BIOSCIENCES INC (NBIX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$167.7MFY2025 · since FY2022: $0 → $167.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $167.7M | -44.1% |
| FY2024 | $300.0M | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX RevenueNBIX Net incomeNBIX Net marginNBIX Gross profitNBIX Gross marginNBIX Operating incomeNBIX Operating marginNBIX Operating cash flowNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →